Our Boston Laboratory

Bioanalytical Services & Diagnostic Testing in the Heart of the World’s Biotech Center

BioAgilytix’s Boston laboratory is located in the heart of the world’s biotech innovation hub and boasts a 20-plus-year track record of delivering premier bioanalytical services along with specialized diagnostic testing.

This facility houses seasoned scientists that collectively have developed, optimized, and validated hundreds of assays for innovative biologic drugs across an array of disease states. We support the full assay lifecycle, from optimization or technology transfer to full validation. This lab can also perform routine sample testing for LDTs or assays developed in-house. We support pharmacetuical and biotechnology innovators of all sizes in their efforts to progress innovative new large molecule drugs to market.

Tell Us About Your Project

What are your specific assay needs? Let’s schedule a conversation to review your questions and requirements with one of our scientists.


Through BioAgilytix Diagnostics – a division of BioAgilytix and part of our CLIA-certified, CAP-accredited, New York State-licensed Boston laboratory – we offer diagnostic testing services to reference labs for a diverse range of clinical samples, accepted from all 50 states.

We specialize in esoteric testing using FDA-cleared assays and laboratory developed tests (LDTs) for infectious disease testing, diagnostic immunology, vitamin testing, parasite-borne infection testing, and more.

To learn more and explore our full test menu, click here.


At our CLIA-certified, CAP-accredited, and GLP/GCLP-compliant Boston laboratory, we provide premier services for assay development, validation, clinical sample testing, diagnostic testing, kit production, and project management in alignment with a stringent quality system. Our team works across wide range of therapeutic areas and technology platforms to support all aspects of bioanalytical testing for clinical trials. Our test methods include PK/PD analysis, immunogenicity, cell-based assays, biomarker analysis, and more.

Our work supports development programs for all biologics, including gene and cell therapies, antibody-drug conjugates (ADCs), and immuno-oncology solutions. Learn more about our capabilities related to: